These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27060213)

  • 1. The influence of type 2 diabetes on serum GH and IGF-I levels in hospitalized Japanese patients.
    Suda K; Matsumoto R; Fukuoka H; Iguchi G; Hirota Y; Nishizawa H; Bando H; Yoshida K; Odake Y; Takahashi M; Sakaguchi K; Ogawa W; Takahashi Y
    Growth Horm IGF Res; 2016 Aug; 29():4-10. PubMed ID: 27060213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus.
    Al-Shoumer KA; Al-Asousi AA; Doi SA; Vasanthy BA
    Ann Saudi Med; 2008; 28(5):367-70. PubMed ID: 18779635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive correlation between serum IGF-1 and HDL-C in type 2 diabetes mellitus.
    Song X; Teng J; Wang A; Li X; Wang J; Liu Y
    Diabetes Res Clin Pract; 2016 Aug; 118():44-9. PubMed ID: 27322526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of growth hormone-binding protein in altered GH-IGF axis in IDDM.
    Kobayashi K; Amemiya S; Kobayashi K; Sawanobori E; Mochizuki M; Ishihara T; Higashida K; Miura M; Nakazawa S
    Endocr J; 1999 Mar; 46 Suppl():S67-9. PubMed ID: 12054124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between insulin-like growth factor with glycemic control, glomerular filtration rate, blood pressure, hematological changes or body mass index in patients with type 2 diabetes mellitus.
    NeamŢu MC; Avramescu ET; Marcu IR; Turcu-Ştiolică A; Boldeanu MV; NeamŢu OM; Tudorache Ş; Dănciulescu Miulescu RE
    Rom J Morphol Embryol; 2017; 58(3):857-861. PubMed ID: 29250665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intensive glycemic control on serum levels of insulin-like growth factor-I and dehydroepiandrosterone sulfate in Type 2 diabetes mellitus.
    Kanazawa I; Yamaguchi T; Sugimoto T
    J Endocrinol Invest; 2012 May; 35(5):469-72. PubMed ID: 21997284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of haemoglobin A1c to detect impaired fasting glucose or Type 2 diabetes in a United Kingdom community based population.
    Kumaravel B; Bachmann MO; Murray N; Dhatariya K; Fenech M; John WG; Scarpello TJ; Sampson MJ;
    Diabetes Res Clin Pract; 2012 May; 96(2):211-6. PubMed ID: 22257419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual beta-cell function more than glycemic control determines abnormalities of the insulin-like growth factor system in type 1 diabetes.
    Hedman CA; Frystyk J; Lindström T; Chen JW; Flyvbjerg A; Ørskov H; Arnqvist HJ
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6305-9. PubMed ID: 15579794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus.
    Salgado LR; Semer M; Nery M; Knoepfelmacher M; Lerário AC; Póvoa G; Jana S; Villares SM; Wajchenberg BL; Liberman B; Nicolau W
    J Endocrinol Invest; 1996; 19(7):433-40. PubMed ID: 8884537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion.
    Shishko PI; Dreval AV; Abugova IA; Zajarny IU; Goncharov VC
    Diabetes Res Clin Pract; 1994 Aug; 25(1):1-12. PubMed ID: 7530621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly.
    Schmid HA; Brue T; Colao A; Gadelha MR; Shimon I; Kapur K; Pedroncelli AM; Fleseriu M
    Endocrine; 2016 Jul; 53(1):210-9. PubMed ID: 26906713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent changes in body composition in postmenopausal Japanese women: relationship to growth hormone secretion as well as serum levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Sugimoto T; Nakaoka D; Nasu M; Kanzawa M; Sugishita T; Chihara K
    Eur J Endocrinol; 1998 Jun; 138(6):633-9. PubMed ID: 9678529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets.
    Mata-Cases M; Mauricio D; Franch-Nadal J
    J Diabetes; 2017 Jan; 9(1):34-44. PubMed ID: 26749415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM.
    Hanaire-Broutin H; Sallerin-Caute B; Poncet MF; Tauber M; Bastide R; Chalé JJ; Rosenfeld R; Tauber JP
    Diabetologia; 1996 Dec; 39(12):1498-504. PubMed ID: 8960832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of estimated average glucose to fasting plasma glucose level is superior to glycated albumin, hemoglobin A1c, fructosamine, and GA/A1c ratio for assessing β-cell function in childhood diabetes.
    Lee JE; Lee JW; Fujii T; Fujii N; Choi JW
    Biomed Res Int; 2014; 2014():370790. PubMed ID: 25013775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation analysis of IGF-1, ZAG, nesfatin-1, HbA1c levels, and type 2 diabetes mellitus complicated with hypothyroidism.
    He S; He Y; Jin F; Liu Y
    Medicine (Baltimore); 2021 Apr; 100(15):e25432. PubMed ID: 33847643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical application of glycosylated hemoglobin A1c and glycated albumin values in cirrhosis patients with hyperglycemia].
    Shao F; Li Q; Jia W
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):506-10. PubMed ID: 26359011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index.
    Zang H; Jiang F; Cheng X; Xu H; Hu X
    Endocr J; 2018 Jul; 65(7):685-691. PubMed ID: 29669965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.